Results 11 to 20 of about 64,733 (242)

Antifungals and Drug Resistance

open access: yesEncyclopedia, 2022
Antifungal drugs prevent topical or invasive fungal infections (mycoses) either by stopping growth of fungi (termed fungistatic) or by killing the fungal cells (termed fungicidal).
Chowdhury Mobaswar Hossain   +6 more
doaj   +2 more sources

Antifungal drug resistance: an update. [PDF]

open access: yesEur J Hosp Pharm, 2022
The number of antifungal classes is small, and resistance is becoming a much more frequent problem. Much greater emphasis needs to be placed on susceptibility testing and antifungal stewardship. Such efforts demonstrably improve survival and overall clinical outcomes.
Denning DW.
europepmc   +5 more sources

Antifungal resistance in dermatophytosis: A global health concern

open access: yesLetters in Animal Biology, 2022
Dermatophytosis is a common dermatological problem in animals as well as humans which is associated with interference in immune function. Unlike the antibacterial resistance which is frequently reported, antifungal resistance is less commonly reported ...
Jubeda Begum, P Das
doaj   +1 more source

Molecular mechanisms governing antifungal drug resistance. [PDF]

open access: yesNPJ Antimicrob Resist, 2023
AbstractFungal pathogens are a severe public health problem. The leading causative agents of systemic fungal infections include species from the Candida, Cryptococcus, and Aspergillus genera. As opportunistic pathogens, these fungi are generally harmless in healthy hosts; however, they can cause significant morbidity and mortality in immunocompromised ...
Lee Y, Robbins N, Cowen LE.
europepmc   +3 more sources

Potential Strategies to Control the Risk of Antifungal Resistance in Humans: A Comprehensive Review

open access: yesAntibiotics, 2023
Fungal infections are becoming one of the main causes of morbidity and mortality in people with weakened immune systems. Mycoses are becoming more common, despite greater knowledge and better treatment methods, due to the regular emergence of resistance ...
Ali A. Rabaan   +19 more
doaj   +1 more source

Molecular Mechanisms of Antifungal Drug Resistance in Candida Species [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2018
Invasive Candidal infections have emerged as one of the major threats to the world. Although, many new antifungal drugs have been developed in the recent years, the emergence of drug resistance has become a major deterrent in the antifungal therapy ...
Lakshmi Krishnasamy   +3 more
doaj   +1 more source

Examining Signatures of Natural Selection in Antifungal Resistance Genes Across Aspergillus Fungi

open access: yesFrontiers in Fungal Biology, 2021
Certain Aspergillus fungi cause aspergillosis, a set of diseases that typically affect immunocompromised individuals. Most cases of aspergillosis are caused by Aspergillus fumigatus, which infects millions of people annually.
Renato Augusto Corrêa dos Santos   +7 more
doaj   +1 more source

Update on Antifungal Drug Resistance. [PDF]

open access: yesCurr Clin Microbiol Rep, 2015
Invasive fungal infections remain a major source of global morbidity and mortality, especially among patients with underlying immune suppression. Successful patient management requires antifungal therapy. Yet, treatment choices are restricted due to limited classes of antifungal agents and the emergence of antifungal drug resistance.
Perlin DS, Shor E, Zhao Y.
europepmc   +4 more sources

Histone Acetylation Regulator Gcn5 Mediates Drug Resistance and Virulence of Candida glabrata

open access: yesMicrobiology Spectrum, 2022
Candida glabrata is poised to adapt to drug pressure rapidly and acquire antifungal resistance leading to therapeutic failure. Given the limited antifungal armamentarium, there is an unmet need to explore new targets or therapeutic strategies for ...
Shuying Yu   +7 more
doaj   +1 more source

Mechanisms of Antifungal Drug Resistance. [PDF]

open access: yesCold Spring Harb Perspect Med, 2014
Antifungal therapy is a central component of patient management for acute and chronic mycoses. Yet, treatment choices are restricted because of the sparse number of antifungal drug classes. Clinical management of fungal diseases is further compromised by the emergence of antifungal drug resistance, which eliminates available drug classes as treatment ...
Cowen LE   +4 more
europepmc   +5 more sources

Home - About - Disclaimer - Privacy